521 Phase II studiesof Nivolumab inpatients withAdvanced Squamous(SQ) or Non-Squamous(NSQ) Non-Small CellLung Cancer (NSCLC) Hiroshi SakaiMakoto NishioTomoyuki Hida2015 год

521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC)
статья из журнала